Spine Pain INtervention to Enhance Care Quality And Reduce Expenditure

ClinicalTrials.gov ID: NCT03083886

Public ClinicalTrials.gov record NCT03083886. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 3, 2026, 6:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Spine Pain INtervention to Enhance Care Quality And Reduce Expenditure - Randomized Clinical Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Low back and neck pain are among the leading causes of medical visits, lost productivity and disability. There is an urgent need to identify effective and efficient ways of helping subjects with acute spine pain while guiding practitioners towards high-value care. This trial will be a block and cluster-randomized open-label multi-centered pragmatic randomized clinical trial comparing healthcare spending and clinical outcomes for subjects with spine pain of less than three months' duration, in whom there are no red flag signs or symptoms. Subjects will be randomized to one of three treatment strategies: (1) usual primary care provider-led care; (2) usual PCP-led care with spine pain treatment directed by the Identify, Coordinate, and Enhanced decision making (ICE) care model, and (3) usual PCP-led care with spine pain treatment directed by the Individualized Postural Therapy (IPT) care model. Our outcomes of interest will be spine-related healthcare utilization at one year as well as pain and functionality of the study participants.

Study identification

NCT ID: NCT03083886
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Brigham and Women's Hospital; Other
Enrollment: 3,087 participants

Conditions and interventions

Conditions

Interventions

Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 4, 2017
Primary completion: Mar 30, 2021
Completion: Jun 29, 2021
Last update posted: Sep 16, 2025

2017 – 2021

United States locations

U.S. sites: 8
U.S. states: 4
U.S. cities: 6

Facility	City	State	ZIP	Site status
HonorHealth Medical Group	Phoenix	Arizona	85255	—
Marwan A. Edris, MD	Laguna Hills	California	92653	—
Teresa S. Sligh, MD	North Hollywood	California	91606	—
Augusto Focil, MD	Oxnard	California	93030	—
Vanderbilt University Medical Center	Nashville	Tennessee	37232	—
Carlos R. Herrera, MD	Houston	Texas	77013	—
Luis Zepeda, MD	Houston	Texas	77017	—
Bernadette U. Iguh, MD	Houston	Texas	77051	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03083886, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 16, 2025 · Synced Sep 3, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03083886 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →